Tag: Weight loss

Investing in Eli Lilly now could mimic early Nvidia gains in AI. Learn why GLP-1 drugs are transforming healthcare investing.

UnityPoint Health-Grinnell introduces Neoprobe Gamma Detection for precise breast cancer surgery, enhancing patient care and personalized treatment.

Eli Lilly's Zepbound reduces sleep apnea by up to 52% in trials, showing promise beyond weight loss. FDA approval for ...

Zealand Pharma's stock surged 17% post-positive trial results for its weight loss drug, showing promising 8.6% average weight reduction. Analysts ...

Senate subpoenas Novo's Langa over drug pricing; Jorgensen to testify in September as Novo blames U.S. health system for high ...

Pfizer's interest in the weight loss market is uncertain due to its significant debt of over $70 billion and recent ...

Investigation reveals significant delays in processing complaints against UK drug companies, raising concerns about patient safety and public health. Increased ...

Scientists at Scripps Research have developed a breakthrough technology that allows them to track when brain cells shut off, providing ...

Discover the promising future for investors in Eli Lilly and Company (NYSE: LLY), a leader in the biopharmaceutical industry, with ...

Tech and weight loss stocks have shown significant growth in 2024, driven by technological advancements and increased focus on wellness. ...